Product Information |
|
Registration Number |
BRP-053
|
Generic Name |
Reteplase (Recombinant Tissue Plasminogen Activator)
|
Brand Name |
Mirel
|
Dosage Strength |
10 Units
|
Dosage Form |
Lyophilized Powder For Injection (Iv)
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Antithrombotic
|
Packaging |
USP Type I Glass Vial x 20mL (Box of 1's)
|
Manufacturer |
Reliance Life Sciences Pvt. Ltd. (Plant II)
|
Country of Origin |
India
|
Trader |
|
Importer |
Ambica International Corporation
|
Distributor |
Ambica International Corporation
|
Application Type |
Automatic Renewal
|
Issuance Date |
03 October 2022
|
Expiry Date |
18 July 2028
|